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Background:  Adipose-derived stem cells (ASCs) are 
mesenchymal stem cells that have recently been applied to 
tissue repair and regeneration. Keratinocytes and dermal 
fibroblasts play key roles in cutaneous wound healing. 
Objective: We investigated the paracrine effects of ASCs on 
HaCaT cells (i.e., immortalized human keratinocytes) and 
human dermal fibroblasts to explore the mechanism of the 
effects of ASCs on cutaneous wound healing. Methods: 
HaCaT cells and primary cultured human dermal fibroblasts 
were treated with 50% conditioned medium of ASCs 
(ASC-CM). Viability, in vitro wound healing, and fibroblast- 
populated collagen lattice contraction assays were con-
ducted, and reverse transcription-polymerase chain reaction 
(RT-PCR) for the type I procollagen α1 chain gene was 
performed. Results: The proliferation of HaCaT cells and 
fibroblasts was increased by ASC-CM in the viability assay. 
ASC-CM promoted in vitro wound healing of HaCaT cells 
and increased the contraction of the fibroblast-populated 
collagen lattice. RT-PCR showed that the transcription of the 
type I procollagen α1 chain gene in fibroblasts was up- 
regulated by ASC-CM. Conclusion: The stimulatory effect of 
ASC on cutaneous wound healing may be partially mediated 
by paracrine effects of ASCs on other skin cells. Application 
of ASCs or ASC-derived molecules could be an innovative 
therapeutic approach in the treatment of chronic wounds 
and other conditions. (Ann Dermatol 24(2) 136∼143, 2012)
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INTRODUCTION
Wound healing is a complex chain of events involving 
interactions among different cells and tissues. The 
progression of the wound healing process is impaired in a 
number of medical conditions
1. Although new therapeutic 
methods have been developed, the treatment of many 
chronic wounds remains unsatisfactory, and more effec-
tive treatment strategies are needed. 
Bone marrow-derived mesenchymal stem cells (BMSCs) 
are multipotent stem cells capable of differentiating into 
numerous cell types, including osteoblasts, chondrocytes, 
and adipocytes
2-4. BMSCs can accelerate wound heal-
ing
5,6, but BMSC transplantation requires the harvesting of 
a large amount of bone marrow under general anesthesia, 
which may lead to severe complications. 
Adipose-derived stem cells (ASCs) represent an alternative 
source of multipotent cells with characteristics similar to 
BMSCs
7,8. ASCs are easier to isolate and are relatively 
abundant, which may make them a better stem cell source 
for wound repair and regeneration. Although ASCs com-
bined with atelocollagen matrix improves wound healing 
in healing-impaired db/db mice
9, the effects of ASCs on 
cutaneous wound healing have not been clearly demon-
strated. 
In this study, we investigated the effects of conditioned 
medium of ASCs (ASC-CM) on HaCaT cells (i.e., immor-Effects of ASCs on Keratinocytes and Fibroblasts
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talized human keratinocytes) and human dermal fibro-
blasts to explore the mechanism of action of ASCs in 
cutaneous wound healing.
MATERIALS AND METHODS
All experimental protocols were approved by the Institu-
tional Review Board of the Seoul National University 
Hospital.
Isolation and culture of ASCs, dermal fibroblasts, and 
HaCaT cells
Human subcutaneous adipose tissues were acquired from 
elective liposuction from healthy female donors with 
informed consent. The suctioned fat was digested with 
0.075% collagenase type I (Sigma-Aldrich, St. Louis, MO, 
USA) in phosphate-buffered saline (PBS) under gentle 
agitation for 30 minutes at 37
oC, and centrifuged at 800× 
g for 10 minutes to obtain the stromal cell fraction. The 
pellets were resuspended, passed through a 100-mm mesh 
filter (Millipore, Billerica, MA, USA), and cultured at 37°C 
in 5% CO2 in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum, 100 
mg/ml streptomycin, and 100 U/ml penicillin. After 3 
days, the culture medium was changed to MesenPRO 
RS
TM Medium (Invitrogen, Carlsbad, CA, USA), and the 
medium was replaced every 3 days. The primary cells were 
cultured until 80% confluence and were defined as passage 
1. For the experiment, ASCs were used at passage 4.
Dermal fibroblasts were harvested from foreskin obtained 
from donors under informed consent and cultured as 
previously described
10. Fibroblasts at passages 4∼6 were 
used for the experiment. HaCaT cells were cultured in 
DMEM supplemented with 10% fetal bovine serum, 100 




Cultured ASCs at passage 4 were characterized by 
immunostaining with antibody, using anti-CD29, anti- 
CD44 (Dako, Glostrup, Denmark), anti-CD31 (Novocastra, 
Newcastle, UK), and anti-CD34 (Becton Dickinson, Franklin 
Lakes, NJ, USA).
Induced differentiation of cultured ASCs
Capacities to differentiate along adiopogenic and osteo-
genic lineages were examined. Cell differentiation was 
initiated when ASCs at passage 4 were confluent in 35 
mm-diameter culture dishes. For adipogenic differen-
tiation, ASCs were incubated for 3 weeks in the culture 
medium supplemented with 0.5 mM isobutylmethylxanthine 
(Sigma-Aldrich), 1 μM dexamethasone, 10 μM insulin, 
and 200 μM indomethacin. Fixed cells (4% parafor-
maldehyde for 10 minutes) were washed with 60% iso-
propanol and incubated for 15 minutes with Oil red O to 
visualize lipid droplets. For osteogenic differentiation, 
cells were incubated for 3 weeks in the culture medium 
supplemented with 0.1 μM dexamethasone, 50 μM 
ascorbate-2-phosphate, and 10 mM β-glycerophosphate. 
Alkaline phosphatase staining was performed according to 
the manufacturer’s instructions (BCIP/NBT color develop-
ment substrate; Promega, Madison, MI, USA). Calcium 
deposits were detected by Alizarin red S staining.
Preparation of ASC-CM
Eighty percent confluent ASCs at passage 4 in 100 
mm-diameter culture dishes were fed with 5 ml of serum- 
free DMEM and incubated at 37
oC in an atmosphere of 
5% CO2/95% air for 48 hours. At the end of the incu-
bation period, the media were collected and centrifuged 
at 300× g for 10 minutes to avoid contamination of cell 
fragments, and the supernatant was used as ASC-CM. 
Thiozolyl blue [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide] (MTT) assay of viability
Cell proliferation was assessed using the MTT assay. 
Briefly, HaCaT cells and dermal fibroblasts were seeded in 
wells of 24-well culture plates at 5×10
3 cells/well and 
incubated at 37
oC in an atmosphere of 5% CO2/95% air. 
The next day, the cells were fed with serum-free DMEM 
for 24 hours, and then treated with serum-free DMEM 
(control medium) or 50% ASC-CM for 4 days. After 
removing the medium from each well, 300 μl of 0.5 
mg/ml MTT solution was added and incubated for 3 hours 
at 37
oC in the dark. The supernatant was removed, and 
formazan crystals were dissolved in 200 μl of dimethyl 
sulfoxide. The dimethyl sulfoxide solution was transferred 
into 96-well plates and the optical density was measured 
at 570 nm using a spectrophotometer. 
In vitro wound healing assay
Confluent HaCaT cells in six-well culture plates were fed 
with serum-free DMEM. After 24 hours, the monolayer 
was scratched with a sterile plastic micropipette tip. The 
cells were washed three times with PBS, and serum-free 
DMEM (control medium) or 50% ASC-CM was added. 
Photographs of the wounds were taken at 0, 24, and 48 
hours by phase-contrast microscopy, and the width of 
healed area was measured by the Image J analysis pro-
gram (National Institutes of Health, Bethesda, MD, USA).SH Lee, et al
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Fig. 1. Adipose-derived stem cells at 
passage 4 expressed CD29 and 
CD44, whereas hematopoietic cell 
marker CD31 and CD34 were not 
expressed (immunoperoxidase, ×100).
Fibroblast-populated collagen lattice contraction assay
Five milliliters of bovine serum albumin (Sigma-Aldrich) 
solution was pipetted into each well of a six-well plate 
and incubated at 37
oC for 1 hour. Collagen solution 
mixture was prepared by quickly mixing eight volumes of 
collagen type I solution (Nitta Gelatin, Tokyo, Japan) with 
one volume of 10-fold concentrated DMEM and one 
volume of sodium bicarbonate (22 mg/ml). Dermal 
fibroblasts were added to the collagen solution mixture at 
a concentration of 3×10
5 cells/ml and gently mixed. 
Collagen solution mixture with fibroblasts (1.5 ml) was 
poured into each well of a 6-well plate after bovine serum 
albumin solution was removed, and allowed to gel for 30 
minutes in 5% CO2/95% air at 37
oC. The fibroblast- 
populated collagen lattices were detached from the 
surface of the well by rimming the lattices with a sterile 
needle and gently swirling the plate. Serum-free DMEM 
(control medium) or 50% ASC-CM was added to each 
well. After 5 days, digital photographs were taken and the 
size of the collagen lattice was measured by the Image J 
analysis program. 
Reverse transcription-polymerase chain reaction (RT-PCR)
The expression of type I procollagen α1 chain gene in 
dermal fibroblasts was assessed by RT-PCR. Dermal 
fibroblasts were cultured in serum-free DMEM or 50% 
ASC-CM for 6 hours. Total RNA was isolated using TRIzol 
reagent (Invitrogen), and cDNA was synthesized with a 
cDNA synthesis kit (Promega). For PCR amplification, a 
20-μl reaction mixture containing 1 U of Taq DNA 
polymerase, 250 μM dNTP, 10 mM Tris-HCl (pH 9.0), 40 
mM KCl, and 1.5 mM MgCl2 was used. To ensure that a 
similar amount of cDNA was used for PCR, samples were 
also assessed for expression of h36B4 as a standard house-
keeping gene. Nucleotide sequences of the PCR primers 
were as follows: type I procollagen α1 chain sense: CTC 
GAG GTG GAC ACC ACC CT, antisense: CAG CTG GAT 
GGC CAC ATC GG: h36B4 sense: TCG ACA ATG GCA 
GCA TCT AC, antisense: TGA TGC AAC AGT TGG GTA 
GC. Thermal cycling consisted of denaturation for 1 
minute at 90
oC, annealing for 1 minute at 60°C and 
extension for 2 minutes at 72
oC. The PCR program 
consisted of amplification cycles for type I procollagen α
1 chain and 25 for h36B4. After electrophoresis on 1.5% 
agarose gel, PCR bands were visualized by ultraviolet 
illumination.
Statistical analysis
Results were expressed as means±standard error of the 
mean. Mann-Whitney U test was used for statistical analysis, 
and a value of p＜0.05 was considered statistically signifi-
cant.Effects of ASCs on Keratinocytes and Fibroblasts
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Fig. 2. Adipose-derived stem cell 
(ASCs) could differentiate toward the 
adipogenic and osteogenic lineages.
ASCs at passage 4 were treated with
adipogenic medium (A, B) or osteo-
genic medium (C∼E) for 3 weeks. 
Oil red O staining (B), alkaline phos-
phatase staining (D), and Alizarin 
red S staining (E) were performed to
confirm adipo- and osteogenesis.
RESULTS
Characterization of ASCs
ASCs expressed mesenchymal stem cell markers CD29 
and CD44, and were negative for hematopoietic markers 
CD31 and CD34 (Fig. 1). ASCs treated with adipogenic 
medium developed intracellular lipid-containing droplets 
that accumulated the lipid dye Oil red O (Fig. 2A and 2B). 
ASCs cultured in osteogenic medium formed aggregates, 
and stained positively for alkaline phosphatase (Fig. 2C, 
D). Calcium deposits were observed in Alizarin red S 
staining (Fig. 2E).
ASC-CM enhances the proliferation of HaCaT cells and 
dermal fibroblasts
Treatment with 50% ASC-CM for 4 days significantly 
increased the proliferation of HaCaT cells and dermal 
fibroblasts compared with the vehicle-treated control (p＜ 
0.05) (Fig. 3). The proliferation of HaCaT cells was enhanced 
more than that of dermal fibroblasts by ASC-CM 
(218.8±17.3% vs. 126.9±3.3%).
ASC-CM promotes in vitro wound healing of HaCaT 
cells
In the in vitro wound healing assay, 50% ASC-CM signifi-
cantly enhanced the wound healing by 2.43-fold over 
control level after 24-hour incubation (130.91±33.46 μm 
vs. 53.81±6.23 μm,  p＜0.05) (Fig. 4). Treatment with 
50% ASC-CM for 48 hours also promoted wound healing 
by the same degree (267.73±42.56 μm vs. 110.25± 
12.35 μm, p＜0.05).
Contraction of fibroblast-populated collagen lattice is 
enhanced by ASC-CM
To evaluate the effect of ASC-CM on the ability of dermal 
fibroblasts to contract collagen lattices, 50% ASC-CM was SH Lee, et al
140 Ann Dermatol
Fig. 3. Proliferation of HaCaT cells and dermal fibroblasts was
increased by the conditioned medium of adipose-derived stem
cell (ASC-CM) in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide assay. HaCaT cells and dermal fibroblasts were
treated with 50% ASC-CM or Dulbecco’s modified Eagle’s medium
(control) for 4 days. The values shown are the mean±standard
error of the mean of six independent experiments performed in
triplicate wells. *p＜0.05 vs. the control group.
Fig. 4. The conditioned medium of adipose-derived stem cell (ASC-CM) promote in vitro wound healing of HaCaT cells. (A) Monolayers 
of confluent HaCaT cells were wounded with a micropipette tip, and then treated with 50% ASC-CM or Dulbecco’s modified Eagle’s 
medium (control). Photographs were taken at 24 hours and 48 hours. (B) The width of healed area was calculated with an image 
analysis program. The values shown are the mean±standard error of the mean of six independent experiments. *p＜0.05 vs. the 
control group.
added to the floating fibroblast-populated collagen lattice 
and the size of the collagen lattice was measured after 5 
days. ASC-CM significantly reduced the size of collagen 
lattice compared with vehicle-treated control (6.22±0.51 
cm
2 vs. 7.73±0.10 cm
2, p＜0.05) (Fig. 5).     
ASC-CM up-regulates the transcription of type I 
procollagen α1 chain gene in dermal fibroblasts
Treatment with 50% ASC-CM for 6 hours significantly 
increased the mRNA expression of the type I procollagen 
α1 chain gene in dermal fibroblasts by 1.27-fold over 
vehicle-treated control (p＜0.05) (Fig. 6).
DISCUSSION
ASCs are multipotent cells that can differentiate along 
multiple cell lineages, including adipogenic, osteogenic, 
and chondrogenic pathways
7,8. The cultured ASCs of this 
study could differentiate into adipogenic and osteogenic 
lineages in specific culture medium. ASCs showed the 
same immunophenotypes as previously described
7,11. 
They expressed the mesenchymal stem cell markers CD29 
and CD44, but not the hematopoietic markers CD31 and 
CD34.
Cutaneous wound healing is a dynamic, interactive 
process involving the interaction of cells in the dermis and 
epidermis, including fibroblasts and keratinocytes, as well 
as the release of chemical mediators from inflammatory Effects of ASCs on Keratinocytes and Fibroblasts
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Fig. 5. The conditioned medium of adipose-derived stem cell (ASC-CM) increased the contraction of fibroblast-populated collagen 
lattice. (A) Collagen lattice was treated with 50% ASC-CM or Dulbecco’s modified Eagle’s medium (control) for 5 days. (B) The size
of collagen lattice was measured with an image analysis program. The values shown are the mean±standard error of the mean of
six independent experiments. *p＜0.05 vs. the control group.
Fig. 6. Transcription of type I procollagen α1 chain gene is up-regulated in fibroblasts by the conditioned medium of adipose-derived
stem cell (ASC-CM). (A) Fibroblasts were treated with 50% ASC-CM or Dulbecco’s modified Eagle’s medium (control) for 6 hours
and then reverse transcription-polymerase chain reaction was performed. (B) The values of densitometric quantification are the 
mean±standard error of the mean of six independent experiments. *p＜0.05 vs. the control group.
cells. Wound healing proceeds in three overlapping phases: 
inflammation, tissue formation, and tissue remodeling
12. 
Keratinocytes, fibroblasts, and endothelial cells play essen-
tial roles in the wound healing process including re-epi-
thelialization, granulation tissue formation, and angio-
genesis.
ASCs combined with atelocollagen matrix improve wound 
healing in healing-impaired db/db mice
9, and a condi-
tioned medium of ASCs alone accelerates wound healing 
in mice
13. These results indicate that the paracrine effects 
of ASCs have an important role in their stimulatory effect 
on wound healing. ASCs have a stimulatory effect on 
endothelial cells in a paracrine fashion. Proangiogenic 
factors such as vascular endothelial growth factor (VEGF) 
are secreted at a high level from ASCs, and ASC-CM 
accelerates the proliferation of endothelial cells
11,13. This 
paracrine effect of ASCs is thought be one of the pro-
angiogenic mechanisms of ASCs in vivo
11. In the case of 
keratinocytes and dermal fibroblasts, the paracrine effects 
of ASCs have not been well demonstrated. In limited 
studies, conditioned media of ASCs promoted the prolife-
ration, migration, and production of extracellular matrix 
components of dermal fibroblasts
13,14.
During re-epithelialization, a wedge-shaped mass of kera-
tinocytes moves across the granulation tissue. At the 
leading edge of the wedge are migrating keratinocytes, 
which leave a stratified layer of proliferating keratinocytes. 
The keratinocytes that participate in these processes of 
migration and proliferation are derived from at least two 
anatomic locations including those cells in close proxi-
mity to the wound and epidermal cells of nearby hair 
bulges
15. Keratinocytes are stimulated to migrate and SH Lee, et al
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proliferate by a number of factors during re-epitheliali-
zation. Among growth factors and cytokines, epidermal 
growth factor (EGF) and transforming growth factor (TGF)-
β play a role in keratinocyte migration
16,17. In addition, 
keratinocyte proliferation is stimulated by EGF, basic 
fibroblast growth factor (bFGF) and insulin-like growth 
factor (IGF)-1
17,18. Conditioned media of BMSCs promote 
the proliferation and migration of mouse keratinocytes
6, 
but the effects of ASC-CM on keratinocytes have not been 
demonstrated. Our study revealed that ASC-CM enhances 
the proliferation of HaCaT cells (i.e., immortalized human 
keratinocytes) and accelerates in vitro wound healing of 
HaCaT cells.
Fibroblasts are the most important mesenchymal cells 
involved in wound healing. Fibroblasts in the dermis 
around a wound proliferate and migrate into the wound 
space. After migrating into the wound, they commence 
the synthesis of extracellular matrix components, including 
types I and III collagen, and participate in the formation of 
granulation tissue
15. Platelet-derived growth factor (PDGF), 
TGF-β, nerve growth factor, and connective tissue growth 
factor (CTGF) act as chemoattractants for fibroblasts
19. 
EGF, FGF, PDGF, TGF-β, CTGF, and IGF-1 promote the 
proliferation of fibroblasts, and the collagen production of 
fibroblasts is also stimulated by a number of growth 
factors, including FGF-2, PDGF, TGF-β, CTGF, and 
IGF-1
19,20. In this study, ASC-CM increased the prolife-
ration and transcription of type I procollagen α1 chain 
gene of fibroblasts. These results are similar to a previous 
report
14, and ASC-CM harvested under hypoxia promotes 
collagen synthesis compared with that harvested under 
normoxia
13. 
During the tissue remodeling phase of wound healing, the 
wound begins to contract. Fibroblasts assume a myofibro-
blast phenotype characterized by large bundles of actin- 
containing microfilaments disposed along the cytoplasmic 
face of the plasma membrane of the cells
12. The appea-
rance of the myofibroblasts corresponds to the commen-
cement of contraction of the wound. TGF-β1 or β2 and 
PDGF stimulate the phenotype change of fibroblasts to 
myofibroblasts and wound contraction
21,22. The effects of 
ASC-CM on wound contraction or contractility of fibro-
blasts have not been reported. In this study, ASC-CM 
increased the contraction of fibroblast-populated collagen 
lattice, suggesting that ASC-CM induce the phenotype 
change of fibroblasts to myofibroblasts.  
ASCs produce various growth factors including PDGF, 
IGF, keratinocyte growth factor, bFGF, TGF-β, hepatocyte 
growth factor, and VEGF
14,23, and hypoxic conditions 
stimulate the production of some of these
13. The effects of 
ASC-CM on HaCaT cells and fibroblasts may largely 
depend on the complex action of these cytokines. 
In conclusion, our data demonstrate that ASCs enhance 
the functions of keratinocytes and dermal fibroblasts in a 
paracrine fashion. The stimulatory effect of ASCs on cuta-
neous wound healing may be partially mediated by the 
paracrine effects of ASCs on other skin cells. Application 
of ASCs or ASCs-derived molecules could be an innova-
tive therapeutic approach in the treatment of chronic 
wounds and other conditions.
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